title: The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems.
authors.affiliation: MHRI, U Mich, Ann Arbor 48109.
authors.forename: A
authors.initials: A
authors.lastname: Mansour
authors.forename: J H
authors.initials: JH
authors.lastname: Meador-Woodruff
authors.forename: D M
authors.initials: DM
authors.lastname: Camp
authors.forename: T E
authors.initials: TE
authors.lastname: Robinson
authors.forename: J
authors.initials: J
authors.lastname: Bunzow
authors.forename: H
authors.initials: H
authors.lastname: Van Tol
authors.forename: O
authors.initials: O
authors.lastname: Civelli
authors.forename: H
authors.initials: H
authors.lastname: Akil
authors.forename: S J
authors.initials: SJ
authors.lastname: Watson
mesh_terms: D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004745:Enkephalins / Q000378:metabolism*; D006892:Hydroxydopamines / Q000494:pharmacology; D016627:Oxidopamine; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011954:Receptors, Dopamine / Q000145:classification / Q000187:drug effects / Q000378:metabolism*; D013378:Substantia Nigra / Q000187:drug effects / Q000378:metabolism*; D014018:Tissue Distribution
chemical_list: D004745:Enkephalins; D006892:Hydroxydopamines; D012333:RNA, Messenger; D011954:Receptors, Dopamine; D016627:Oxidopamine